logo
logo

Vivasure Medical Announces Series D Financing To Advance Portfolio Of Perqseal Vessel Closure Devices

Vivasure Medical Announces Series D Financing To Advance Portfolio Of Perqseal Vessel Closure Devices

05/17/22, 12:00 PM
Round Type
series d
Vivasure Medical® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing of the first tranche of €22 million ($23M) as part of its Series D financing round that could reach up to €52 million ($54M) in total. Led by a multi-national strategic corporation, the financing includes an option to buy the Company upon certain milestones. Other participants in this Series D financing round include a second strategic corporate investor as well as existing investors, Fountain Healthcare Partners, Orchestra BioMed, LSP Health Economics Fund managed by the EQT Life Sciences team, Panakès Partners and Evonik Venture Capital.

Company Info

Company
Vivasure Medical
Additional Info
Based in Galway, Ireland, Vivasure is a medical device company developing advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery. Vivasure operates a fully integrated R&D and ISO 13485 certified manufacturing facility and is backed by leading international medtech investors. For more information, please visit www.vivasuremedical.com. PerQseal®, PerQseal®+ and PerQseal® Blue are not available for sale in the United States.